3 unknown. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 3 |
| Phase 2 | 2 | Unknown 2 |
Follow Vulvitis: new trials by email Literature Review of Vulvitis trials Research Report on Vulvitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal Infection BGY-1601-VT, PLACEBO - Bacterial Vaginosis, Vulvovaginal Candidiasis | Phase 1 / Phase 2 | Unknown | NEXBIOME THERAPEUTICS | 165 | 2024-07-08 | 2024-06-12 |
| Patients With Vulvovaginal Candidiasis EPP-AF Gel 1%, EPP-AF Gel 2%, Clotrimazole - Vulvovaginal Candidiasis | Phase 1 / Phase 2 | Unknown | University of Sao Paulo | 90 | 2018-01-30 | 2018-10-19 |
| Use of Oral Probiotics as an Adjunctive Therapy to Fluconazole in the Treatment of Yeast Vaginitis Probiotics (Natural product), Probiotics (L. rhamnosus GR-1 and L. reuteri RC-14) - Vaginal Candidiasis | Phase 1 | Unknown | Faith Mediplex | 100 | 2007-05-01 | 2007-05-30 |
Candidiasis, Vulvovaginal (3) · Vaginitis (1) · Vaginosis, Bacterial (1)
Bacterial Infections and Mycoses (3) · Candidiasis (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Genital Diseases (3) · Genital Diseases, Female (3) · Infections (3) · Mycoses (3) · Urogenital Diseases (3) · Vaginal Diseases (3) · Vulvar Diseases (3) · Vulvovaginitis (3) · Vaginitis (2) · Bacterial Infections (1)
Biological Products (1) · Clotrimazole (1) · Probiotics (1)
Faith Mediplex (1) · NEXBIOME THERAPEUTICS (1) · University of Sao Paulo (1)
Brazil (1) · Nigeria (1)